Skip to main content
Erschienen in: Wiener klinische Wochenschrift 5-6/2024

26.09.2022 | original article

Comparison of physiological responses after incremental shuttle walking test and 6-minute walk test in patients with systemic sclerosis

verfasst von: Buse Ozcan Kahraman, PhD, Aylin Tanriverdi, MSc, Nazenin Hande Sezgin, MSc, Serap Acar, PhD, Ahmet Merih Birlik, MD, Aydan Koken Avsar, MD, Bahri Akdeniz, MD, Ebru Ozpelit, MD, Sema Savci, PhD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 5-6/2024

Einloggen, um Zugang zu erhalten

Summary

Background

The 6‑minute walk test (6MWT) is a commonly used to evaluate exercise capacity in patients with systemic sclerosis (SSc), but there was no study using the incremental shuttle walking test (ISWT) for assessing exercise capacity and comparing the patient’s cardiorespiratory responses to these tests. The aim was to investigate the usability and determinants of the ISWT in patients with SSc and compare the physiological responses after the ISWT and 6MWT.

Methods

A total of thirty four female patients with SSc were included. Dyspnea during daily activities and knee extensor muscle strength was assessed, skin fibrosis and disease severity were recorded, and 6MWT and ISWT were carried out for the exercise capacity measurement. Pulmonary function test results were recorded from the individuals’ medical records for SSc with interstitial lung disease (SSc-ILD) patients.

Results

The ISWT distance was significantly correlated with the 6MWT distance (p < 0.001). The 6MWT was correlated with age, modified Rodnan skin score, Medsger severity score, modified British Medical Research Council Questionnaire (mMRC) score, and knee extensor muscle strength (p < 0.05). The 6MWT was correlated with the forced expiratory volume in the first second (FEV1) (lt) and forced vital capacity (FVC) (lt) in patients with SSc-ILD (p < 0.05). The ISWT distance was correlated with age, modified Rodnan skin score, mMRC score, and knee extensor muscle strength (p < 0.05). Age, mMRC, and knee extensor muscle strength explained 33.8% of the variance in 6MWT distance, while age, mMRC, and knee extensor muscle strength explained 51.7% of the variance in the ISWT distance.

Conclusion

Because of the higher cardiopulmonary responses, and having a more standardized procedure, the ISWT may be preferable for investigating symptom-limited exercise capacity in patients with SSc. Age, dyspnea, and knee extensor muscle strength were the determinants of exercise capacity in patients with SSc.
Literatur
1.
Zurück zum Zitat Hachulla E, Launay D. Diagnosis and classification of systemic sclerosis. Clin Rev Allergy Immunol. 2011;40(2):78–83.CrossRefPubMed Hachulla E, Launay D. Diagnosis and classification of systemic sclerosis. Clin Rev Allergy Immunol. 2011;40(2):78–83.CrossRefPubMed
2.
Zurück zum Zitat Barnabe C, Joseph L, Belisle P, Labrecque J, Edworthy S, Barr SG, et al. Prevalence of systemic lupus erythematosus and systemic sclerosis in the First Nations population of Alberta, Canada. Arthritis Care Res (Hoboken). 2012;64(1):138–43.CrossRefPubMed Barnabe C, Joseph L, Belisle P, Labrecque J, Edworthy S, Barr SG, et al. Prevalence of systemic lupus erythematosus and systemic sclerosis in the First Nations population of Alberta, Canada. Arthritis Care Res (Hoboken). 2012;64(1):138–43.CrossRefPubMed
3.
Zurück zum Zitat Lima TR, Guimarães FS, Carvalho MN, Sousa TL, Menezes SL, Lopes AJ. Lower limb muscle strength is associated with functional performance and quality of life in patients with systemic sclerosis. Braz J Phys Ther. 2015;19(2):129–36.CrossRefPubMedPubMedCentral Lima TR, Guimarães FS, Carvalho MN, Sousa TL, Menezes SL, Lopes AJ. Lower limb muscle strength is associated with functional performance and quality of life in patients with systemic sclerosis. Braz J Phys Ther. 2015;19(2):129–36.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Pettersson H, Åkerström A, Nordin A, Svenungsson E, Alexanderson H, Boström C. Self-reported physical capacity and activity in patients with systemic sclerosis and matched controls. Scand J Rheumatol. 2017;46(6):490–5.CrossRefPubMed Pettersson H, Åkerström A, Nordin A, Svenungsson E, Alexanderson H, Boström C. Self-reported physical capacity and activity in patients with systemic sclerosis and matched controls. Scand J Rheumatol. 2017;46(6):490–5.CrossRefPubMed
5.
Zurück zum Zitat Cuomo G, Santoriello C, Polverino F, Ruocco L, Valentini G, Polverino M. Impaired exercise performance in systemic sclerosis and its clinical correlations. Scand J Rheumatol. 2010;39(4):330–5.CrossRefPubMed Cuomo G, Santoriello C, Polverino F, Ruocco L, Valentini G, Polverino M. Impaired exercise performance in systemic sclerosis and its clinical correlations. Scand J Rheumatol. 2010;39(4):330–5.CrossRefPubMed
6.
Zurück zum Zitat Rosato E, Romaniello A, Magrì D, Bonini M, Sardo L, Gigante A, et al. Exercise tolerance in systemic sclerosis patients without pulmonary impairment: correlation with clinical variables. Clin Exp Rheumatol. 2014;32(6 Suppl 86):103–8. Rosato E, Romaniello A, Magrì D, Bonini M, Sardo L, Gigante A, et al. Exercise tolerance in systemic sclerosis patients without pulmonary impairment: correlation with clinical variables. Clin Exp Rheumatol. 2014;32(6 Suppl 86):103–8.
7.
Zurück zum Zitat Garin MC, Highland KB, Silver RM, Strange C. Limitations to the 6‑minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma. J Rheumatol. 2009;36(2):330–6.CrossRefPubMed Garin MC, Highland KB, Silver RM, Strange C. Limitations to the 6‑minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma. J Rheumatol. 2009;36(2):330–6.CrossRefPubMed
8.
Zurück zum Zitat Villalba WO, Sampaio-Barros PD, Pereira MC, Cerqueira EM, Leme CA Jr, Marques-Neto JF, et al. Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients. Chest. 2007;131(1):217–22.CrossRefPubMed Villalba WO, Sampaio-Barros PD, Pereira MC, Cerqueira EM, Leme CA Jr, Marques-Neto JF, et al. Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients. Chest. 2007;131(1):217–22.CrossRefPubMed
9.
Zurück zum Zitat Medsger TA Jr, Rodnan GP, Moossy J, Vester JW. Skeletal muscle involvement in progressive systemic sclerosis (scleroderma). Arthritis Rheum. 1968;11(4):554–68.CrossRefPubMed Medsger TA Jr, Rodnan GP, Moossy J, Vester JW. Skeletal muscle involvement in progressive systemic sclerosis (scleroderma). Arthritis Rheum. 1968;11(4):554–68.CrossRefPubMed
10.
11.
Zurück zum Zitat Pugnet G, Marjanovic Z, Deligny C, Boussardon K, Benzidia I, Puyade M, et al. Reproducibility and utility of the 6‑minute walk test in systemic sclerosis. J Rheumatol. 2018;45(9):1273–80.CrossRefPubMed Pugnet G, Marjanovic Z, Deligny C, Boussardon K, Benzidia I, Puyade M, et al. Reproducibility and utility of the 6‑minute walk test in systemic sclerosis. J Rheumatol. 2018;45(9):1273–80.CrossRefPubMed
12.
Zurück zum Zitat Singh SJ, Puhan MA, Andrianopoulos V, Hernandes NA, Mitchell KE, Hill CJ, et al. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1447–78.CrossRefPubMed Singh SJ, Puhan MA, Andrianopoulos V, Hernandes NA, Mitchell KE, Hill CJ, et al. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1447–78.CrossRefPubMed
13.
Zurück zum Zitat Deboeck G, Niset G, Vachiery JL, Moraine JJ, Naeije R. Physiological response to the six-minute walk test in pulmonary arterial hypertension. Eur Respir J. 2005;26(4):667–72.CrossRefPubMed Deboeck G, Niset G, Vachiery JL, Moraine JJ, Naeije R. Physiological response to the six-minute walk test in pulmonary arterial hypertension. Eur Respir J. 2005;26(4):667–72.CrossRefPubMed
14.
Zurück zum Zitat Pepin V, Saey D, Whittom F, LeBlanc P, Maltais F. Walking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172(12):1517–22.CrossRefPubMed Pepin V, Saey D, Whittom F, LeBlanc P, Maltais F. Walking versus cycling: sensitivity to bronchodilation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172(12):1517–22.CrossRefPubMed
15.
Zurück zum Zitat Labadessa IG, Borghi-Silva A, de Araujo ASG, Rizzatti FPG, Di Lorenzo VAP. Reliability of cardiorespiratory and metabolic responses during incremental shuttle walk test in adult subjects with asthma. Respir Care. 2019;64(1):55–62.CrossRefPubMed Labadessa IG, Borghi-Silva A, de Araujo ASG, Rizzatti FPG, Di Lorenzo VAP. Reliability of cardiorespiratory and metabolic responses during incremental shuttle walk test in adult subjects with asthma. Respir Care. 2019;64(1):55–62.CrossRefPubMed
16.
Zurück zum Zitat Singh S, Moiz JA, Ali MS, Talwar D. Reliability, validity, and responsiveness of the incremental shuttle walk test in patients with interstitial lung disease. J Cardiopulm Rehabil Prev. 2018;38(6):425–9.CrossRefPubMed Singh S, Moiz JA, Ali MS, Talwar D. Reliability, validity, and responsiveness of the incremental shuttle walk test in patients with interstitial lung disease. J Cardiopulm Rehabil Prev. 2018;38(6):425–9.CrossRefPubMed
17.
Zurück zum Zitat Hanson LC, Taylor NF, McBurney H. The 10 m incremental shuttle walk test is a highly reliable field exercise test for patients referred to cardiac rehabilitation: a retest reliability study. Physiotherapy. 2016;102(3):243–8.CrossRefPubMed Hanson LC, Taylor NF, McBurney H. The 10 m incremental shuttle walk test is a highly reliable field exercise test for patients referred to cardiac rehabilitation: a retest reliability study. Physiotherapy. 2016;102(3):243–8.CrossRefPubMed
18.
Zurück zum Zitat Medsger TA Jr, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W. Assessment of disease severity and prognosis. Clin Exp Rheumatol. 2003;21(3 Suppl 29):S42–S6.PubMed Medsger TA Jr, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W. Assessment of disease severity and prognosis. Clin Exp Rheumatol. 2003;21(3 Suppl 29):S42–S6.PubMed
19.
Zurück zum Zitat Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995;22(7):1281–5.PubMed Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 1995;22(7):1281–5.PubMed
20.
Zurück zum Zitat Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–6.CrossRefPubMedPubMedCentral Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–6.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat O’Shea SD, Taylor NF, Paratz JD. Measuring muscle strength for people with chronic obstructive pulmonary disease: retest reliability of hand-held dynamometry. Arch Phys Med Rehabil. 2007;88(1):32–6.CrossRefPubMed O’Shea SD, Taylor NF, Paratz JD. Measuring muscle strength for people with chronic obstructive pulmonary disease: retest reliability of hand-held dynamometry. Arch Phys Med Rehabil. 2007;88(1):32–6.CrossRefPubMed
22.
Zurück zum Zitat American Thoracic Society, American College of Chest Physicians. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167(2):211–77.CrossRef American Thoracic Society, American College of Chest Physicians. ATS/ACCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003;167(2):211–77.CrossRef
23.
Zurück zum Zitat Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428–46.CrossRefPubMed Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428–46.CrossRefPubMed
24.
Zurück zum Zitat Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J. 1999;14(2):270–4.CrossRefPubMed Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J. 1999;14(2):270–4.CrossRefPubMed
25.
Zurück zum Zitat Ross RM, Murthy JN, Wollak ID, Jackson AS. The six minute walk test accurately estimates mean peak oxygen uptake. BMC Pulm Med. 2010;10:31.CrossRefPubMedPubMedCentral Ross RM, Murthy JN, Wollak ID, Jackson AS. The six minute walk test accurately estimates mean peak oxygen uptake. BMC Pulm Med. 2010;10:31.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Probst VS, Hernandes NA, Teixeira DC, Felcar JM, Mesquita RB, Gonçalves CG, et al. Reference values for the incremental shuttle walking test. Respir Med. 2012;106(2):243–8.CrossRefPubMed Probst VS, Hernandes NA, Teixeira DC, Felcar JM, Mesquita RB, Gonçalves CG, et al. Reference values for the incremental shuttle walking test. Respir Med. 2012;106(2):243–8.CrossRefPubMed
27.
Zurück zum Zitat Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377–81.CrossRefPubMed Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377–81.CrossRefPubMed
28.
Zurück zum Zitat Bozdemir Ozel C, Arikan H, Demirtas RN, Saglam M, Calik-Kutukcu E, Vardar-Yagli N, et al. Evaluation of exercise capacity using two field tests in patients with metabolic syndrome. Disabil Rehabil. 2021;43(7):1015–21.CrossRefPubMed Bozdemir Ozel C, Arikan H, Demirtas RN, Saglam M, Calik-Kutukcu E, Vardar-Yagli N, et al. Evaluation of exercise capacity using two field tests in patients with metabolic syndrome. Disabil Rehabil. 2021;43(7):1015–21.CrossRefPubMed
29.
Zurück zum Zitat Travensolo C, Goessler K, Poton R, Pinto RR, Polito MD. Measurement of physical performance by field tests in programs of cardiac rehabilitation: a systematic review and meta-analysis. Rev Port Cardiol. 2018;37(6):525–37.CrossRefPubMed Travensolo C, Goessler K, Poton R, Pinto RR, Polito MD. Measurement of physical performance by field tests in programs of cardiac rehabilitation: a systematic review and meta-analysis. Rev Port Cardiol. 2018;37(6):525–37.CrossRefPubMed
30.
Zurück zum Zitat Pulz C, Diniz RV, Alves AN, Tebexreni AS, Carvalho AC, de Paola AA, et al. Incremental shuttle and six-minute walking tests in the assessment of functional capacity in chronic heart failure. Can J Cardiol. 2008;24(2):131–5.CrossRefPubMedPubMedCentral Pulz C, Diniz RV, Alves AN, Tebexreni AS, Carvalho AC, de Paola AA, et al. Incremental shuttle and six-minute walking tests in the assessment of functional capacity in chronic heart failure. Can J Cardiol. 2008;24(2):131–5.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Oliver N, Onofre T, Carlos R, Barbosa J, Godoy E, Pereira E, et al. Ventilatory and metabolic response in the incremental shuttle and 6‑min walking tests measured by telemetry in obese patients prior to bariatric surgery. Obes Surg. 2015;25(9):1658–65.CrossRefPubMed Oliver N, Onofre T, Carlos R, Barbosa J, Godoy E, Pereira E, et al. Ventilatory and metabolic response in the incremental shuttle and 6‑min walking tests measured by telemetry in obese patients prior to bariatric surgery. Obes Surg. 2015;25(9):1658–65.CrossRefPubMed
32.
Zurück zum Zitat Morales FJ, Martínez A, Méndez M, Agarrado A, Ortega F, Fernández-Guerra J, et al. A shuttle walk test for assessment of functional capacity in chronic heart failure. Am Heart J. 1999;138(2 Pt 1):291–8.CrossRefPubMed Morales FJ, Martínez A, Méndez M, Agarrado A, Ortega F, Fernández-Guerra J, et al. A shuttle walk test for assessment of functional capacity in chronic heart failure. Am Heart J. 1999;138(2 Pt 1):291–8.CrossRefPubMed
33.
Zurück zum Zitat Green DJ, Watts K, Rankin S, Wong P, O’Driscoll JG. A comparison of the shuttle and 6 minute walking tests with measured peak oxygen consumption in patients with heart failure. J Sci Med Sport. 2001;4(3):292–300.CrossRefPubMed Green DJ, Watts K, Rankin S, Wong P, O’Driscoll JG. A comparison of the shuttle and 6 minute walking tests with measured peak oxygen consumption in patients with heart failure. J Sci Med Sport. 2001;4(3):292–300.CrossRefPubMed
34.
Zurück zum Zitat Celli BR, Rassulo J, Make BJ. Dyssynchronous breathing during arm but not leg exercise in patients with chronic airflow obstruction. N Engl J Med. 1986;314(23):1485–90.CrossRefPubMed Celli BR, Rassulo J, Make BJ. Dyssynchronous breathing during arm but not leg exercise in patients with chronic airflow obstruction. N Engl J Med. 1986;314(23):1485–90.CrossRefPubMed
35.
Zurück zum Zitat Sanges S, Giovannelli J, Sobanski V, Morell-Dubois S, Maillard H, Lambert M, et al. Factors associated with the 6‑minute walk distance in patients with systemic sclerosis. Arthritis Res Ther. 2017;19(1):279.CrossRefPubMedPubMedCentral Sanges S, Giovannelli J, Sobanski V, Morell-Dubois S, Maillard H, Lambert M, et al. Factors associated with the 6‑minute walk distance in patients with systemic sclerosis. Arthritis Res Ther. 2017;19(1):279.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Antoniou KM, Margaritopoulos GA, Goh NS, Karagiannis K, Desai SR, Nicholson AG, et al. Combined pulmonary fibrosis and emphysema in scleroderma-related lung disease has a major confounding effect on lung physiology and screening for pulmonary hypertension. Arthritis Rheumatol. 2016;68(4):1004–12.CrossRefPubMed Antoniou KM, Margaritopoulos GA, Goh NS, Karagiannis K, Desai SR, Nicholson AG, et al. Combined pulmonary fibrosis and emphysema in scleroderma-related lung disease has a major confounding effect on lung physiology and screening for pulmonary hypertension. Arthritis Rheumatol. 2016;68(4):1004–12.CrossRefPubMed
37.
Zurück zum Zitat Deuschle K, Weinert K, Becker MO, Backhaus M, Huscher D, Riemekasten G. Six-minute walk distance as a marker for disability and complaints in patients with systemic sclerosis. Clin Exp Rheumatol. 2011;29(2 Suppl 65):S53–S9.PubMed Deuschle K, Weinert K, Becker MO, Backhaus M, Huscher D, Riemekasten G. Six-minute walk distance as a marker for disability and complaints in patients with systemic sclerosis. Clin Exp Rheumatol. 2011;29(2 Suppl 65):S53–S9.PubMed
38.
Zurück zum Zitat Buch MH, Denton CP, Furst DE, Guillevin L, Rubin LJ, Wells AU, et al. Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6‑min walk test. Ann Rheum Dis. 2007;66(2):169–73.CrossRefPubMed Buch MH, Denton CP, Furst DE, Guillevin L, Rubin LJ, Wells AU, et al. Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6‑min walk test. Ann Rheum Dis. 2007;66(2):169–73.CrossRefPubMed
39.
Zurück zum Zitat Suliman YA, Dobrota R, Huscher D, Nguyen-Kim TD, Maurer B, Jordan S, et al. Brief report: pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease. Arthritis Rheumatol. 2015;67(12):3256–61.CrossRefPubMed Suliman YA, Dobrota R, Huscher D, Nguyen-Kim TD, Maurer B, Jordan S, et al. Brief report: pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease. Arthritis Rheumatol. 2015;67(12):3256–61.CrossRefPubMed
Metadaten
Titel
Comparison of physiological responses after incremental shuttle walking test and 6-minute walk test in patients with systemic sclerosis
verfasst von
Buse Ozcan Kahraman, PhD
Aylin Tanriverdi, MSc
Nazenin Hande Sezgin, MSc
Serap Acar, PhD
Ahmet Merih Birlik, MD
Aydan Koken Avsar, MD
Bahri Akdeniz, MD
Ebru Ozpelit, MD
Sema Savci, PhD
Publikationsdatum
26.09.2022
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 5-6/2024
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-022-02087-y

Weitere Artikel der Ausgabe 5-6/2024

Wiener klinische Wochenschrift 5-6/2024 Zur Ausgabe

MUW researcher of the month

MUW researcher of the month

mitteilungen der gesellschaft der ärzte in wien

Lange Nacht der Notfallambulanzen in Wien